503A, 503B, peptide, GLP-1, and telehealth fulfillment.
Compounded pharmacies fulfilling telehealth prescriptions occupy a specific processor lane. The 503A individualized-prescription framework, 503B outsourcing-facility framework, LegitScript pharmacy certification, DEA-registered controlled substance handling, and direct-to-patient shipping compliance all show up in underwriting. Aggregators cannot underwrite this vertical structurally. Direct acquirer placement at pharmacy-friendly banks is the path.
503A pharmacies compound patient-specific prescriptions under state pharmacy board oversight; the DTC subscription pattern makes this high-risk. 503B outsourcing facilities produce for office stock under direct FDA oversight; the B2B healthcare institution pattern reads as moderate-risk with different chargeback exposure.
Internet pharmacy certification is 995 dollars initial plus 1,995 dollars annually. Healthcare merchant certification for the telehealth platform partner is separate. Most acquirers require LegitScript at boarding or accept in-progress certification with expected completion date.
503B B2B: 3 to 6 percent rolling. 503A local dispensing: 4 to 7 percent. 503A DTC telehealth: 8 to 15 percent depending on product mix. GLP-1-heavy and peptide-heavy pharmacies board at the higher end.
Ketamine, testosterone HRT Schedule III, and Schedule II pain management compounding require DEA registration plus controlled substance policy documentation. Additional reserve loading applies. Placement at acquirers with active DEA-registered underwriting appetite.
2026 boarding requires documentation that GLP-1 fulfillment is FDA-approved product dispensed under label or 503A-individualized with clinical rationale. Bulk 503A GLP-1 without individualized-prescription documentation does not underwrite.
Pharmacies fulfilling for named telehealth brands board on the same underwriting framework as any other 503A pharmacy: prescriber relationship contracts, prescription verification protocols, direct-to-patient shipping compliance, LegitScript certification. Telehealth partner brand does not change the underwriting outcome; the pharmacy's own documentation does.